Physician profile
Kelsey Doyle
NPI 1194293399
$423.71
in general payments reported to CMS, 2019-2025
11 companies · $180 in 2025
The $180 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $44.40 · 2024: $199 · 2025: $180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $379.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $379.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $124.95 | 2024-2025 | |
| Novo Nordisk INC | $80.46 | 2024-2025 | Wegovy |
| Masimo Corporation | $44.40 | 2022 | |
| Lilly USA, LLC | $38.96 | 2024 | Mounjaro, Zepbound |
| Astellas Pharma US INC | $33.82 | 2024-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $21.97 | 2024 | |
| Tactile Systems Technology INC | $21.43 | 2024 | Entre Plus, Flexitouch Plus |
| Astrazeneca Pharmaceuticals LP | $14.91 | 2025 | Airsupra |
| Merck Sharp & Dohme LLC | $14.50 | 2025 | Capvaxive, Gardasil 9 |
| Glaxosmithkline, LLC. | $14.16 | 2024 | Trelegy Ellipta |
| Exact Sciences Corporation | $14.15 | 2025 | The Cologuard Plus Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelsey Doyle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.